跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mucinex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mucinex
Approved
STANDARD
Mucinex
Reckitt Benckiser Healthcare International Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e93b6ee8da6edc4c
Company
Reckitt Benckiser Healthcare International Limited
Type
Standard
Approval Details
Approval Id
e93b6ee8da6edc4c
Drug Approval Philippines Name
Mucinex
Product Name
Mucinex
Registration Number
DR-XY42612
Brand Name
Mucinex
Generic Name
Guaifenesin
Dosage Form
Extended Release Tablet
Dosage Strength
600mg
Manufacturer
Reckitt Benckiser Healthcare International Limited
Importer
Reckitt Benckiser Healthcare (Philippines), Inc.
Company Detail Path
/organization/reckitt-benckiser-healthcare-international-limited
Importer Detail Path
/organization/reckitt-benckiser-healthcare-philippines-inc
Issuance Date
23 November 2020
Expiry Date
12 January 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e93b6ee8da6edc4c
Type
Standard
Back to Philippines FDA Approvals